🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of tenofovir...
Status
Completed
Location
Faculdade de Medicina - UFMG
Start Date
2006-06
Trial ID
NCT00352053
Treatments Being Tested
Study ING116529 is a multicenter, randomized, study with an initial 7 day p...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-18
Trial ID
NCT01568892
Treatments Being Tested
To demonstrate statistically significant and clinically meaningful effects ...
Status
Completed
Location
Markham Stouffville Hospital
Start Date
2018-01-30
Trial ID
NCT03287960
Treatments Being Tested
The primary objectives of the study are to estimate the effects of REGN4461...
Status
Completed
Location
Regeneron Research Site
Start Date
2020-01-07
Trial ID
NCT04159415
Treatments Being Tested
The purpose of this trial is to determine whether delamanid is effective in...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-02
Trial ID
NCT01424670
Treatments Being Tested
Two cohorts are being studied based on leptin levels. Cohort A is composed ...
Status
Terminated
Location
Excel Medical Clinical Trials - A Flourish Research Site
Start Date
2022-02-28
Trial ID
NCT05088460
Treatments Being Tested
The purpose of this phase III study is to evaluate the efficacy between tre...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-01
Trial ID
NCT04406727
Treatments Being Tested
The purpose of this study is research with the goal of evaluating the effec...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00254046
The primary objective of this study is to evaluate the antiviral activity o...
Status
Active Not Recruiting
Location
Ruane Clinical Research Group Inc
Start Date
2019-11-21
Trial ID
NCT04150068
Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in vitro ...
Status
Completed
Location
Alabama Therapeutics CRS
Start Date
2007-11
Trial ID
NCT00515827
Treatments Being Tested